H.R. 4541 · 119th Congress · Health
EARLY Act and SCREENS for Cancer Act
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
How the House voted
Yea from the left, nay from the right, each side by party
Bundled: this vote covered more than one measure.
House · Jul 20, 2026
Roll call ↗394
6
Passed the House.
Two separately titled Acts joined in one vote: the EARLY Act reauthorization in title I and the SCREENS for Cancer Act in title II. The coupling is narrow because both concern breast and cervical cancer detection. Title I extends a single sunset from 2026 to 2031; title II rewrites and funds a separate CDC screening program at $235,500,000 a year through 2030. The displayed title names only the title I subject and omits the SCREENS for Cancer Act entirely.
Passed the House on July 20, 2026.
Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions
- IntroducedJul 17, 2025
- CommitteeJul 13, 2026
- Passed HouseJul 20, 2026
- Passed Senate
- Became law
On the record
- Cosponsors
- 20
- 15 Democrats, 5 Republicans
- Committees
- Senate Committee on Health, Education, Labor, and PensionsHouse Committee on Energy and Commerce
- Lobbying
- At least 6
- organizations named it2025 Q3 to 2026 Q3
What it does
The bill carries two titles.
How each member voted
The House roll call, passed the House, July 20, 2026
Yea unless marked
D · House · NC-12
R · House · AL-4
D · House · CA-33
R · House · MO-4
R · House · GA-12
The bill carries two titles. Title I, the EARLY Act Reauthorization of 2025, extends the sunset of the Young Women's Breast Health Education and Awareness Requires Learning Young Act by striking 2026 and inserting 2031 in the Public Health Service Act, continuing the CDC breast-health education program for young women through 2031. Title II, the SCREENS for Cancer Act of 2025, rewrites the National Breast and Cervical Cancer Early Detection Program in Title XV of the Public Health Service Act. It adds program purposes covering prevention, navigation of care, and reducing disparities in breast and cervical cancer, changes the required program report from annual to once every 5 years, and authorizes $235,500,000 for each of fiscal years 2026 through 2030. It also directs the Comptroller General to report to Congress by September 30, 2027 on the program's reach and any barriers to screening.
Each stop is a step the bill’s own record states, with the date it happened. A ring is a step not yet taken. A bill becomes law when the President signs it or Congress overrides a veto.
At least 6 organizations named this measure in a lobbying filing. A floor, not a total: they were counted by the client name on 22 quarterly reports filed by 1 lobbying firm and by 5 organizations lobbying for themselves in 2025 Q3, 2025 Q4, 2026 Q1, 2026 Q2 and 2026 Q3. An organization that lobbied this measure without naming it is not counted here.
The filings record that lobbying was reported on the measure. The form has no per-bill dollar figure and no field for a position, so nothing here says how much was spent or which side an organization took.
5 of them, in no ranking: The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen; American Cancer Society Cancer Action Network Inc; Hadassah, the Women's Zionist Organization of America, Inc.; GE Healthcare Technologies Inc.; Susan G. Komen. Listed as filed, in the order the filings were read, and 1 other is not shown. These are not the largest, the earliest or the most active: we keep five names per measure, and the filings give no ranking.
From the LD-2 quarterly lobbying filings published at lda.gov by the Senate Office of Public Records. Read for 2025 Q1, 2025 Q2, 2025 Q3, 2025 Q4, 2026 Q1, 2026 Q2 and 2026 Q3. Our copy holds 24 fewer filings for 2025 Q1, 39 fewer filings for 2025 Q2, 42 fewer filings for 2025 Q3, 33 fewer filings for 2025 Q4, 28 fewer filings for 2026 Q1, 48 fewer filings for 2026 Q2 and 218 fewer filings for 2026 Q3 than the Senate's register counts, so those quarters are the filings we could read rather than every one filed. 2026 Q4 is still inside its filing window, so that quarter is only the filings posted so far.
Congress.gov bill status and cosponsor records; the House Clerk and Senate roll calls; lobbying reports filed under the Lobbying Disclosure Act (lda.gov); the plain summary and provisions are read from the bill text, each with its section.